ALDX - Aldeyra Therapeutics Inc
IEX Last Trade
5.76
0.385 6.684%
Share volume: 741,167
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.38
0.39
7.16%
Summary score
23%
Profitability
25%
Dept financing
7%
Liquidity
50%
Performance
19%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.76%
Return on assets
-17.39%
Return on sales
0%
Return on invested capital
192.99%
Total debt ratio
17.01%
Debt ratio change over timeo
-0.9%
Current Ratio
11.01%
Quick Ratio
0%
Cash Position Ratio
5.14%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.27%
Return on assets
-16.7%
Return on sales
0%
Return on invested capital
159.71%
Total debt ratio
32%
Debt ratio change over timeo
-0.8%
Current Ratio
9.88%
Quick Ratio
0%
Cash Position Ratio
4.22%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.25%
Return on assets
-9.92%
Return on sales
0%
Return on invested capital
159.47%
Total debt ratio
26.3%
Debt ratio change over time
-0.88%
Current Ratio
14.52%
Quick Ratio
0%
Cash Position Ratio
10.3%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-111.83%
Return on assets
-109.29%
Return on sales
0%
Return on invested capital
3.7%
Total debt ratio
-90.38%
Debt ratio change over time
-0.9%
Current Ratio
4.9%
Quick Ratio
0%
Cash Position Ratio
1.55%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALDX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -21.76% | -3.05% | 11.55% | 6.27% |
| Return on assets | -17.39% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 192.99% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 17.01% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.9% | 6.09% | 6.03% | 1.53% |
| Dept financing | 4% | 50% | 43% | 14% |
| Current Ratio | 9.88% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.22% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 17% | 36% | 37% |
| Short-term ratios | ALDX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.27% | -25.62% | 17.94% | 7.14% |
| Return on assets | -16.7% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 159.71% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 71% | 60% |
| Total debt ratio | 32% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.8% | -23.44% | 9.66% | 0.6% |
| Dept financing | 8% | 25% | 45% | 8% |
| Current Ratio | 9.88% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.22% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 31% | 25% | 43% |